BELLUS Health to Participate in the 2021 RBC Capital Markets Global Healthcare Conference Biotech Investing
Bellus Health, Inc. Investors: Last Days to Participate Actively in the Class Action Lawsuit; Portnoy Law Firm Biotech Investing
SOLITON ALERT: Bragar Eagel & Squire, P.C. Investigates Sale of SOLY and Encourages Investors to Contact the Firm Biotech Investing
Last Few Days to Actively Participate in BELLUS Health Inc. Class Action and Lead Plaintiff Deadline: May 17, 2021 - Bronstein, Gewirtz & Grossman, LLC Biotech Investing
MONDAY DEADLINE ALERT: The Schall Law Firm Reminds Investors of Class Action Lawsuit Against BELLUS Health Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm Biotech Investing
Optimi Health and Numinus Wellness Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application Cannabis Investing News
Numinus Wellness and Optimi Health Submit All-Natural Psilocybin Extract to Health Canada for Pre-Clinical Trial Application Cannabis Investing News
New National Eye Institute Data Shows AREDS2 Nutrient Formula Continues To Reduce The Risk Of Moderate To Advanced Age-Related Macular Degeneration Progression Medical Device Investing
Pfizer and BioNTech Receive First U.S. Authorization for Emergency Use of COVID-19 Vaccine in Adolescents Pharmaceutical Investing
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of Soliton, Inc. Buyout Biotech Investing
